Mount Sinai Recruits Internationally Recognized Ophthalmologists to Expand Leadership
New appointments will enhance pediatric care, research, and education
Mount Sinai Health System announced the appointment of two new faculty members to expand leadership in the Department of Ophthalmology. Louis R. Pasquale, MD, FARVO, has been named Site Chair of Ophthalmology at The Mount Sinai Hospital and Mount Sinai Queens and will also serve as Vice Chair of Translational Ophthalmology Research for the Mount Sinai Health System. Douglas Fredrick, MD, will become Deputy Chair for Education in the Department of Ophthalmology at the Icahn School of Medicine at Mount Sinai and Chief of Pediatric Ophthalmology for the Mount Sinai Health System.
“The New York City metropolitan region deserves to have one of the world’s leading centers for ophthalmology and vision research, and patient care. I am delighted to welcome these outstanding recruits to help us push the boundaries of discovery and development of new treatments and approaches for complex, blinding eye diseases,” said James C. Tsai, MD, MBA, Delafield-Rodgers Professor and System Chair of Ophthalmology for the Mount Sinai Health System, and President of New York Eye and Ear Infirmary of Mount Sinai (NYEE). “Recruiting top scientific talent is an integral part of enhancing our reputation for providing clinical excellence, innovation, and groundbreaking translational research.”
In his new role, Dr. Pasquale will lead NYEE’s translation of basic vision research to clinical patient care, to help improve their quality of life. He will also utilize big-data and artificial intelligence approaches to guide meaningful population-based care strategies in ophthalmology. Dr. Pasquale has garnered international recognition for his research achievements. His work has highlighted environmental risk factors for exfoliation syndrome, the most common form of secondary open-angle glaucoma, and the role nitric oxide signaling plays in the pathogenesis of primary open-angle glaucoma. Dr. Pasquale has also contributed to resolving the complex genetic architecture of primary open-angle glaucoma. He joins Mount Sinai after spending 25 years at Massachusetts Eye and Ear Infirmary, a teaching hospital of Harvard Medical School.
Dr. Fredrick will work closely with leadership at NYEE and The Mount Sinai Hospital to build upon the Department’s national and international reputation as a premier teaching institution for residents and fellows. He will also lead the expansion of pediatric ophthalmology services to offer enhanced treatment of a wide variety of childhood eye diseases. Dr. Fredrick is internationally recognized for his clinical expertise in the treatment of complicated strabismus, pediatric cataracts, cortical visual impairment, and modalities to slow the progression of childhood myopia. He joins the Health System after 11 years at Stanford University, where he served as Residency Program Director and Vice Chair for Education and Clinical Affairs.
Additionally, Paul A. Sidoti, MD, has been named as the new Site Chair of Ophthalmology at NYEE. He previously served as Deputy Chair for Clinical Affairs at NYEE and the Mount Sinai Health System. In this role, Dr. Sidoti will be responsible for the overall efficiency and effectiveness of clinical operations, and for the high level of patient care in ophthalmology throughout NYEE and its satellites. Dr. Sidoti will help develop plans for research and clinical trials, training programs for residents and fellows, continuing medical education programming, and clinical activities in the Department. Dr. Sidoti has been instrumental in the growth of NYEE’s national and international reputation as one of the top medical teaching hospitals for ophthalmology. He will continue in his role as Chief of Glaucoma for Mount Sinai Health System.
Richard Rosen, MD, has been named Deputy Chair for Clinical Affairs in the Department of Ophthalmology at Icahn School of Medicine at Mount Sinai and The Belinda Bingham Pierce & Gerald G. Pierce, MD Distinguished Chair of Ophthalmology at NYEE. As Deputy Chair for Clinical Affairs, Dr. Rosen will be responsible for the overall efficiency and effectiveness of clinical operations for the Department of Ophthalmology at NYEE and its satellite locations. Working in conjunction with members of the senior management team, Dr. Rosen will oversee the administrative and technical management and staff at various satellite locations; monitor the quality assurance program for the clinical services within the Department; and ensure delivery of quality patient care, technical training/education, and compliance with national guidelines/standards. He will continue his role as Vice Chair and Director of Ophthalmology Research, and Director of the Retina Fellowship at NYEE.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area, with more than 43,000 employees working across eight hospitals, over 400 outpatient practices, nearly 300 labs, a school of nursing, and a leading school of medicine and graduate education. Mount Sinai advances health for all people, everywhere, by taking on the most complex health care challenges of our time — discovering and applying new scientific learning and knowledge; developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
Through the integration of its hospitals, labs, and schools, Mount Sinai offers comprehensive health care solutions from birth through geriatrics, leveraging innovative approaches such as artificial intelligence and informatics while keeping patients’ medical and emotional needs at the center of all treatment. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture outpatient surgery centers throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. We are consistently ranked by U.S. News & World Report's Best Hospitals, receiving high "Honor Roll" status, and are highly ranked: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. U.S. News & World Report’s “Best Children’s Hospitals” ranks Mount Sinai Kravis Children's Hospital among the country’s best in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that have earned distinction by multiple indicators: It is consistently ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and top 20 in the nation for National Institutes of Health funding and top 5 in the nation for numerous basic and clinical research areas. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.